Wells Fargo Maintains Boston Scientific at Equal-Weight, Cuts Target to $45
Wells Fargo lowered its price target from $48 to $45 while maintaining its Equal-Weight rating.
Story updates
02:12:52 PM UTC
SquawkNews
Boston Scientific Is Maintained at Equal-Weight by Wells Fargo